WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit with the Schall Law Firm

WGS Investors Have Opportunity to Lead GeneDx Holdings --> Accessibility: Skip TopNav WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit with the Schall Law Firm July 23, 2026 09:47 ET | Source: Schall Law Schall Law LOS ANGELES, July 23, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GeneDx Holdings Corp. (“GeneDx” or “the Company”) (NASDAQ: WGS ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company’s securities between April 16, 2025 and May 4, 2026, inclusive (the “Class Period”), are encouraged to contact the firm before August 3, 2026. If you are a shareholder who suffered a loss, click here to participate . We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com , or by email at [email protected] . The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member. According to the Complaint, the Company made false and misleading statements to the market. GeneDx reported its Q1 2026 financial results on May 4, 2026. The Company revealed a drop in adjusted gross margin, lowered its projected earnings, and announced a $31.3 million impairment related to Fabric Genomics. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about GeneDx, investors suffered damages. Join the case to recover your losses. The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics. CONTACT: The Schall Law Firm Brian Schall, Esq., www.schallfirm.com Office: 310-301-3335 [email protected] SOURCE: The Schall Law Firm Tags GeneDx WGS Class Action GlobeNewswire Recommended Reading July 23, 2026 10:22 ET | Source: Schall Law GRAL Investors Have Opportunity to Lead GRAIL, Inc. Securities Fraud Lawsuit with the Schall Law Firm GRAL Investors Have Opportunity to Lead GRAIL, Inc. Securities Fraud Lawsuit with the Schall Law Firm Read More July 23, 2026 10:11 ET | Source: Schall Law VRRM Investors Have Opportunity to Lead Verra Mobility Corporation Securities Fraud Lawsuit with the Schall Law Firm VRRM Investors Have Opportunity to Lead Verra Mobility Corporation Securities Fraud Lawsuit with the Schall Law Firm Read More